Bing

SEARCH HISTORY

In the after hrs today, we paid special attention to the fact that highly volatile stock ANX has completed a large round of financing. What was a little unusual was the stock price fell well below the offering price: excerpt: .....The warrants will have an ...
Examiner · 1/7/2010
DALLAS, April 23, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring ADVENTRX Pharmaceuticals Inc ... ANX: http://www.boardcentral.com/boards/ANX In the report, the analyst notes: "ANX's net loss applicable …
GlobeNewswire · 4/23/2010
"ANX's net loss applicable to common stock for the fourth quarter of 2009 was $6.5 million, or $0.04 per share, compared to a net loss applicable to common stock of $7.5 million, or $0.08 per share, for the same period in 2008. Included in the net loss ...
News-Medical · 4/23/2010
More from Bing News
I hope you'll continue to follow me here and on Twitter, and if you have a biotech stock question for the Mailbag, I now accept email and tweets. Via Twitter, @dschornnyc asks, " Did you get a chance to see Adventrx Pharmaceuticals(ANX)? Have any …
The Street · ByAdam Feuerstein · 1/15/2010
CytRx Corporation (Nasdaq: CYTR) will receive shares of ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX) common stock based on a definitive agreement for the acquisition of SynthRx, Inc. by ADVENTRX. CytRx holds a 19.1% stake in SynthRx. CytRx …
StreetInsider · 2/14/2011
CytRx also recently received 163,000 shares of common stock in ADVENTRX Pharmaceuticals (ANX) when the specialty pharmaceutical company bought SynthRx, Inc., in which CytRx held a 19.1% stake. If and when ADVENTRX brings ANX-188 to market …
Seeking Alpha · 5/10/2011
Among that small group right now are Elite Pharmaceuticals Inc. (OTC:ELTP), Nexxus Lighting, Inc. (NASDAQ:NEXS), and ADVENTRX Pharmaceuticals, Inc. (AMEX:ANX). Here's a closer ... Pharmaceuticals pushing the stock upward. This is all happening …
Smallcap Network · ByBryan Murphy · 9/26/2012
ADVENTRX PHARMACEUTICALS INC (ANX): Free Stock Analysis Report CARDTRONICS INC (CATM): Free Stock Analysis Report HERTZ GLOBAL HOLDINGS INC (HTZ): Free Stock Analysis Report MERCANTILE BANK CP (MBWM): Free Stock
Yahoo Finance · 7/21/2011
Just last week the company filed an NDA for the drug. It will now focus on developing ANX-514, another reformulation of the cancer drug Taxotere (docetaxel). Adventrx's stock (ANX) has experienced heavy trading since the company filed its NDA last week.
Fierce Biotech · 1/13/2010
Release date- 19062015 - TORONTO - Anaconda Mining Inc. (TSX:ANX) announces certain financial and operating ... the final approval of the private placement by the Toronto Stock Exchange; the grade and recovery of ore which is mined varying from …
4 Traders · 6/22/2015